A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal Cancer
Floudas, Charalampos S., Brar, Gagandeep, Mabry-Hrones, Donna, Duffy, Austin G., Wood, Bradford, Levy, Elliot, Krishnasamy, Venkatesh, Fioravanti, Suzanne, Bonilla, Cecilia M., Walker, Melissa, MorellLanguage:
english
Journal:
Clinical Colorectal Cancer
DOI:
10.1016/j.clcc.2019.06.004
Date:
July, 2019
File:
PDF, 1.04 MB
english, 2019